Delivery Order SPE2DB20D2104-SPE2DB24FQ76P
Award Date
10/16/23
Potential Completion Date
10/17/23
Potential Value
$7.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $2,650.58 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a child contract under its parent company Cencora, Inc. The contract has an ultimate completion date of August 31, 2023 and was awarded on August 30, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,354.96 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,427.76 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, with a completion date of December 15, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a $3,144.38 firm fixed-price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, is for the supply of 4564313232 - Cyclosporine 0.05% eye emulsion with an ultimate completion date of April 18, 2024. Amerisourcebergen holds a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,291.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 15, 2023, with a completion date of February 16, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion for the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,802.97, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a $34,050.15 firm fixed-price delivery order for cyclosporine 0.05% eye emulsion awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses critical medical commodities...
The U.S. Defense Logistics Agency (DLA) awarded a $1,954.08 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a performance period through May 1, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,564,839,949 units of Cyclosporine 0.05% eye emulsion. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $30,801.63 and a completion date of June 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of 4,558,549,115 units of Cyclosporine 0.05% eye emulsion in 60-count packages. The $27,929.37 firm fixed price contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. AmerisourceBergen is a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...